A R T I C L E S
Vignolle et al.
2
2
(d, JCP2 ) 6 Hz, CH3i-Pr), 20.8 (d, JCP2 ) 6 Hz, CH3i-Pr), 24.5 (d,
Experimental Section
3JCP1 ) 3 Hz, CH3Ni-Pr), 24.6 (d, JCP1 ) 2 Hz, CH3Ni-Pr), 24.9 (d,
3
All manipulations were performed under an inert atmosphere of
argon using standard Schlenk techniques. Dry, oxygen-free solvents
were employed. 1H, 13C, and 31P NMR spectra were recorded on Bruker
3JCP1 ) 3 Hz, CH3Ni-Pr), 25.3 (d, JCP1 ) 3 Hz, CH3Ni-Pr), 27.6
3
(dd,1JCP2 ) 18 Hz, JCP1 ) 5 Hz, CHi-Pr), 27.8 (dd,1JCP2 ) 18 Hz,
3
3JCP1 ) 4 Hz, CHi-Pr), 39.2 (dd, JCP1 ) 39 Hz, JCP2 ) 47 Hz, CCl),
AC200, WM250, AMX400, and AMX500 spectrometers. H and 13C
1
2
2
47.4 (d, JCP1 ) 10 Hz, CHN), 47.7 (d, JCP1 ) 11 Hz, CHN), 53.8
(dd, JCP1 ) 42 Hz, JCP2 ) 5 Hz, CH2(allyl)), 63.2 (dd, JCP1 ) 12 Hz, JCP2
) 30 Hz, CH2(allyl)), 116.4 (dd, JCP1 ) 9 Hz, JCP2 ) 5 Hz, CH(allyl)). 3b
was obtained as yellow crystals by recrystallization from toluene at
-30 °C (367 mg, 87%), mp 148 °C. 31P{1H} NMR (C6D6): δ 62.2 (d,
chemical shifts are reported in ppm relative to Me4Si as external
standard. 31P NMR downfield chemical shifts are expressed with a
positive sign, in ppm, relative to external 85% H3PO4. Infrared spectra
were recorded on a Perkin-Elmer 1725X FT-IR spectrometer. Mass
spectra were obtained on a Ribermag R10 10E instrument. The bis-
(diisopropylamino)- and bis(dicyclohexylamino)phosphinodiazomethanes
1a,b were prepared according to the literature procedure.17a
2JPP ) 17 Hz, PNc-Hex2), 36.5 (d, JPP ) 17 Hz, Pi-Pr2). MS (FAB):
2
705 [M + H]+.
Synthesis of Palladium Complexes 7a,b. At -80 °C, pyridine (0.52
mmol, 0.042 mL) was added to a DCM solution (3 mL) of 3a (0.52
mmol, 283 mg) or 3b (0.52 mmol, 364 mg). The solution was warmed
to -30 °C and transferred by canula to a suspension of NaBPh4 (0.57
mmol, 195 mg) in DCM (5 mL). The resulting suspension was warmed
to room temperature and stirred for 30 min. NaCl was filtered off, and
the solvent was evaporated. Recrystallization from CH2Cl2/Et2O af-
forded 7b as yellow crystals (482 mg, 87%), mp 167-169 °C. 31P-
{1H} NMR (CH2Cl2): δ 30.9 (d, JPP ) 4.4 Hz, Pi-Pr2), 66.0 (br, PNc-
Hex2). 7a was also isolated and characterized (400 mg, 85%). 31P{1H}
NMR (CDCl3): δ 34.1 (d, JPP ) 4.9 Hz, Pi-Pr2), 68.7 (d, JPP ) 4.9
Synthesis of Diazo Compound 2a. n-BuLi (8.3 mmol) was added
at -80 °C to a THF solution (20 mL) of bis(diisopropylamino)-
phosphinodiazomethane (8.3 mmol, 2.26 g). After 30 min, chlorodi-
isopropylphosphine (8.3 mmol, 1.32 mL) was added at -80 °C, and
the solution was stirred for 15 min. After the solution warmed to room
temperature, the solvent was removed under vacuum. The crude residue
was extracted with pentane (20 mL) and quickly filtered through neutral
activated alumina. After evaporation of the solvent, 2a was obtained
as a red oil (2.7 g, 84%). 31P{1H} NMR (C6D6): δ 66.4 (d, 2JPP ) 128
2
1
Hz, PNi-Pr2), -2.5 (d, JPP ) 128 Hz, Pi-Pr2). H NMR (C6D6): δ
1.27 (ddd, 6 H, 3JHH ) 7.2 Hz, 3JHP2 ) 16.4 Hz, 5JHP1 ) 1.1 Hz, CH3i-
1
3
3
5
Hz, PNi-Pr2). H NMR (CDCl3): δ 1.00 (br, 3 H, CH3i-Pr), 1.14 (br,
Pr), 1.28 (ddd, 6 H, JHH ) 7.2 Hz, JHP2 ) 16.4 Hz, JHP1 ) 1.3 Hz,
3
3 H, CH3i-Pr), 1.21 (br, 3 H, CH3i-Pr), 1.24 (br, 3 H, CH3i-Pr), 1.24-
1.32 (br, 12 H, CH3N), 1.42 (br, 12 H, CH3N), 2.41 (br, 1 H, CHi-Pr),
2.50 (br, 1 H, CHi-Pr), 2.76 (br, 2 H, CH2(allyl)), 3.86 (br, 2 H, CHN),
3.95 (br, 2 H, CHN), 4.23 (br, 1 H, CH2(allyl)), 4.32 (br, 1 H, CH2(allyl)),
5.16 (m, 1 H, CH(allyl)), 6.85 (br, 3 H, CHPy), 6.95 (br, 4 H, CHBPh),
7.10 (br, 8 H, CHBPh), 7.52 (br, 8 H, CHBPh), 7.82 (br, 2 H, CHPy).
13C{1H} NMR (CDCl3): δ 20.8 (s, CH3i-Pr), 21.0 (s, CH3i-Pr), 22.5
(d, JCP2 ) 8.7 Hz, CH3i-Pr), 22.9 (d, JCP2 ) 8.1 Hz, CH3i-Pr), 24.3 (d,
JCP1 ) 4.7 Hz, CH3Ni-Pr), 24.4 (d, JCP1 ) 4.0 Hz, CH3Ni-Pr), 26.0 (s,
CH3Ni-Pr), 26.2 (s, CH3Ni-Pr), 28.9 (dd, JCP1 ) 5.7 Hz, JCP2 ) 30.4
Hz, CHi-Pr), 29.2 (dd, JCP1 ) 3.9 Hz, JCP2 ) 30.5 Hz, CHi-Pr), 49.6
(d, JCP1 ) 11.0 Hz, CHNi-Pr), 50.6 (d, JCP1 ) 11.5 Hz, CHNi-Pr),
CH3i-Pr), 1.31 (d, 12 H, JHH ) 6.4 Hz, CH3Ni-Pr), 1.43 (d, 12 H,
3JHH ) 6.4 Hz, CH3Ni-Pr), 1.90 (sept, 2 H, JHH ) 7.2 Hz, CHi-Pr),
3
3.49 (sept d, 4 H, JHH ) 6.4 Hz, JHP1 ) 1.6 Hz, CHN). 13C{1H}
3
3
NMR (C6D6): δ 19.5 (d, 2JCP2 ) 8 Hz, CH3i-Pr), 20.4 (dd, 2JCP2 ) 20
4
3
Hz, JCP1 ) 3 Hz, CH3i-Pr), 24.7 (d, JCP1 ) 7 Hz, CH3Ni-Pr), 25.3
(dd,1JCP2 ) 3 Hz, 3JCP1 ) 8 Hz, CHi-Pr), 25.6 (dd,1JCP2 ) 18 Hz, 3JCP1
) 2 Hz, CHi-Pr), 33.0 (dd,1JCP1 ) 36 Hz,1JCP2 ) 71 Hz, CN2), 48.0
(d, JCP1 ) 13 Hz, CHNi-Pr). IR (diethyl ether): νCN2 2012 cm-1
.
2
Synthesis of Diazo Compound 2b. A freshly prepared LDA solution
from diisopropylamine (1.71 mmol, 0.240 mL) and BuLi (1.71 mmol,
1.12 mL) in THF (5 mL) was added at -80 °C to a solution of bis-
(dicyclohexylamino)phosphino diazomethane (1.71 mmol, 738 mg) in
THF (10 mL). After 30 min, chlorodiisopropylphosphine (1.71 mmol,
0.272 mL) was added at -80 °C and stirred for a further 15 min. The
solution was warmed to rt and the volatiles were removed under
vacuum. The crude residue was extracted with pentane and quickly
filtered through celite and neutral activated alumina. After evaporation
of the solvent, compound 2b was obtained as an orange powder.
Recristallisation from Et2O at -30 °C led to compound 2b as orange
crystals (778 mg, 83%): mp 54 °C; 31P{1H} NMR (C6D6): δ 67.6 (d,
2JPP ) 132 Hz, PNc-Hex2), -3.8 (d, 2JPP ) 132 Hz, Pi-Pr2); IR (THF)
60.3 (dd, JCP1 ) 42.0 Hz, JCP2 ) 5.3 Hz, CH2(allyl)), 65.5 (dd, JCP1
13.1 Hz, JCP2 ) 30.7 Hz, CH2(allyl)), 119.2 (dd, JCP1 ) 10.1 Hz, JCP2
)
)
6.2 Hz, CH(allyl)), 122.1 (s, CHBPh), 126.0 (q, JCB ) 2.7 Hz, CHBPh),
127.8 (s, CHPy), 131.7 (s, CHPy), 133.3 (s, CHPy), 136.8 (s, CHBPh),
164.6 (q, JCB ) 49.3 Hz, CBPh); Cylide was not observed.
Synthesis of Palladium Complex 8b. To a THF solution (5 mL)
of 3b (0.37 mmol, 258 mg) was added trimethylphosphine (0.37 mmol,
0.370 mL) at r oom temperature. This solution was transferred by canula
to a suspension of NaBPh4 (0.40 mmol, 137 mg) in 1.5 mL of THF
previously cooled to -80 °C. The suspension was warmed to room
temperature and stirred for 1 h. The solvent was evaporated, and the
solid was washed with Et2O (2 × 5 mL) and extracted with DCM (5
mL). Crystallization from a THF solution and slow diffusion of Et2O
at room temperature afforded 8b as pale yellow crystals (322 mg, 82%),
mp 214-216 °C. 31P{1H} NMR (CDCl3): δ 2.5 (dd, JP3P1 ) 16 Hz,
JP3P2 ) 7 Hz, PMe3), 26.9 (dd, JP2P1 ) 82 Hz, JP2P3 ) 7 Hz, Pi-Pr2),
63.8 (dd, JP1P2 ) 82 Hz, JP1P3 ) 16 Hz, PNc-Hex2). 1H NMR (CDCl3):
δ 1.17 (dd, 3 H, 3JHH ) 7.2 Hz, JHP2 ) 19.2 Hz, CH3i-Pr), 1.22 (m, 12
νCN2 2015 cm-1
.
Synthesis of Palladium Complexes 3a,b. A CH2Cl2 solution (4 mL)
of [PdCl(allyl)]2 dimer (0.3 mmol, 110 mg) was added at -80 °C to a
solution of diazo derivative 2a (0.7 mmol) or 2b (0.7 mmol) in 4 mL
of CH2Cl2. The solution was warmed to room temperature and stirred
for 1 h. After evaporation of the solvent, the crude residue was extracted
with 4 × 10 mL of pentane, yielding 3a as a yellow oily residue (277
2
mg, 85%). 31P{1H} NMR (CD2Cl2): δ 61.2 (d, JPP ) 22 Hz, PNi-
Pr2), 40.1 (d, 2JPP ) 22 Hz, Pi-Pr2). 1H NMR (CD2Cl2): δ 1.10 (dd, 3
3
3
3
3
H, JHH ) 7.2 Hz, JHP2 ) 18.0 Hz, CH3i-Pr), 1.16 (dd, 3 H, JHH
)
H, CH2c-Hex), 1.28 (dd, 3 H, JHH ) 6.8 Hz, JHP2 ) 18.8 Hz, CH3i-
7.2 Hz, 3JHP2 ) 18.0 Hz, CH3i-Pr), 1.18 (dd, 3 H, 3JHH ) 7.2 Hz, 3JHP2
) 15.2 Hz, CH3i-Pr), 1.27 (d, 6 H, 3JHH ) 6.8 Hz, CH3Ni-Pr), 1.28 (d,
Pr), 1.29 (dd, 3 H, 3JHH ) 7.4 Hz, JHP2 ) 17.6 Hz, CH3i-Pr), 1.31 (dd,
3
2
3 H, JHH ) 7.8 Hz, JHP2 ) 16.9 Hz, CH3i-Pr), 1.63 (d, 9 H, JHP3
)
3
3
6 H, JHH ) 6.8 Hz, CH3Ni-Pr), 1.31 (d, 6 H, JHH ) 6.8 Hz, CH3Ni-
12.4 Hz, PMe3), 1.68-2.04 (m, 28 H, CH2c-Hex), 2.15 (sept d d, 1 H,
Pr), 1.34 (d, 6 H, 3JHH ) 6.8 Hz, CH3Ni-Pr), 2.18 (sept d, 1 H, 3JHH
)
3JHH ) 7.2 Hz, JHP1 ) 3.2 Hz, JHP2 ) 10.4 Hz, CHi-Pr), 2.28 (sept d
4
3
3
7.2 Hz, JHP1 ) 1.2 Hz, CHi-Pr), 2.24 (sept d, 1 H, JHH ) 7.2 Hz,
d, 1 H, JHH ) 7.2 Hz, JHP1 ) 3.2 Hz, JHP2 ) 10.4 Hz, CHi-Pr), 2.70
4JHP1 ) 1.2 Hz, CHi-Pr), 2.42 (ddd, 1 H, 3JHH ) 13.2 Hz, JHP1 ) 12.4
(m, 2H, CH2(allyl)), 3.51 (m, 4 H, CHNc-Hex), 4.04 (m, 1 H, CH2(allyl)),
4.14 (tlike, JHH ) 8.4 Hz, JHP1 ) 8.4 Hz, CH2(allyl)), 5.12 (m, 1 H, CH(allyl)),
6.95 (t, 4 H, JHH ) 7.2 Hz, CHBPh), 7.10 (tlike, 8 H, JHH ) 7.2 Hz,
CHBPh), 7.38 (br, 8 H, CHBPh). 13C{1H} NMR (CDCl3): δ 16.9 (d,1JCP
3
Hz, JHP2 ) 1.2 Hz, CH2(allyl)), 2.60 (ddd, 1 H, JHH ) 13.2 Hz, JHP1
)
5.2 Hz, JHP2 ) 8.0 Hz, CH2(allyl)), 3.82 (d, 2 H, 3JHH ) 7.2 Hz, CH2(allyl)),
3
3
4.11 (sept d, 2 H, JHH ) 6.8 Hz, JHP1 ) 18.4 Hz, CHN), 4.15 (sept
d, 2 H, 3JHH ) 6.8 Hz, 3JHP1 ) 18.8 Hz, CHN), 4.91 (m, 1 H, CH(allyl)).
13C{1H} NMR (CD2Cl2): δ 19.9 (s, CH3i-Pr), 20.0 (s, CH3i-Pr), 20.7
) 57.3 Hz, PMe3), 20.0 (d, JCP2 ) 2.6 Hz, CH3i-Pr), 20.1 (d, JCP2
)
2.7 Hz, CH3i-Pr), 22.6 (d, JCP2 ) 6.0 Hz, CH3i-Pr), 22.7 (d, JCP2 ) 6.1
9
984 J. AM. CHEM. SOC. VOL. 129, NO. 4, 2007